Skip to content

A Study on the Homoeopathic Treatment of Allergic Rhinitis.

Effectiveness of Individualized Homoeopathic Medicines in Fifty Millesimal Potency for the Management of Allergic Rhinitis and Improvement in Quality of Life: A Pre-Post Interventional study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097804
Enrollment
42
Registered
2025-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Administration of indicated homoeopathic medicine will be in Fifty Millesimal Potency. Dispensed as 1 medicated globule, size 10 mixed in 100 ml of

Sponsors

Mahesh Bhattacharyya Homoeopathic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Already diagnosed case of allergic rhinitis 2) Patients with Symptoms of Allergic rhinitis (AR) such as nasal discharge, sneezing, nasal congestion, nasal itching supported by elevated Serum Total IgE level (more than 200 IU/ml) 3) Patients of both sexes: age 13-60 years. 4) Patient already undergoing conventional treatment for allergic rhinitis may be recruited after a washout period of 1 month. 5) Patient willing to give informed consent and patitent of age between 13-17 years willing to give Assent and Parent consent to participate in the study

Exclusion criteria

Exclusion criteria: 1) Case of nasal development defect or structural abnormalities nasal polyp, deviated nasal septum 2) Patient having severe co-morbidities of allergic rhinitis like asthma, sinusitis, etc 3) Critically ill patient. 4) Diagnosed case of mental or psychiatric illness 5) Patient with substance abuse 6) Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Primary outcome is to assess the improvement in severity of nasal symptoms using TNSS - Total Nasal Symptom ScoreTimepoint: The outcome data will be collected at baseline and every four weeks up to six months.

Secondary

MeasureTime frame
i. To Assess the improvement in quality of life by Mini RQLQ Rhinoconjunctivitis Quality of Life Questionnaire.Timepoint: The outcome data will be collected at baseline and every four weeks up to six months.;ii. To Assess the change in Serum Total IgE levels measured at baseline and at six months post-intervention.Timepoint: The outcome data will be collected at the baseline and after six months in follow up sheets based on which data assessment will be done.

Countries

India

Contacts

Public ContactDr Madhabananda Saha

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

drmadhabanandasaha@gmail.com9434230785

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026